Biotech & Health

23andMe files for bankruptcy: How to delete your data

DNA testing service 23andMe filed for bankruptcy protection on March 16, sparking concerns about what could happen to the genetic data of the company’s 15 million customers.  23andMe has said that “data privacy will be an important consideration in any potential transaction.” However, security experts and lawmakers have cautioned customers to take action to protect

23andMe files for bankruptcy: How to delete your data Read More »

DNA testing company 23andMe files for bankruptcy protection, CEO resigns

Genetics testing company 23andMe has filed for Chapter 11 bankruptcy protection in the U.S. to initiate the sale of its assets. Alongside the announcement, the company’s co-founder and CEO Anne Wojcicki separately said she is leaving the company to become an independent bidder for the company. “After a thorough evaluation of strategic alternatives, we have

DNA testing company 23andMe files for bankruptcy protection, CEO resigns Read More »

YC-backed ReactWise is applying AI to speed up drug manufacturing

Artificial intelligence continues stirring things up in chemistry. To wit: YC-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacture — a key step in bringing new drugs to market. Once a promising drug has been identified in the lab, pharma firms need to be able to produce much larger amounts of the

YC-backed ReactWise is applying AI to speed up drug manufacturing Read More »

Travis Kalanick wants to do a lot more than develop more ghost kitchens

Last week, at the Abundance Summit in Los Angeles, billionaire entrepreneur Travis Kalanick gave attendees a rare glimpse into his vision for the future of his newest company, CloudKitchens. While today the eight-year-old L.A.-based outfit is known for a growing real estate portfolio that it uses to it host – and set up – restaurants

Travis Kalanick wants to do a lot more than develop more ghost kitchens Read More »

Anti-aging zealot Bryan Johnson wants to start ‘foodome sequencing’

In the same way that genome sequencing determines the genetic makeup of an organism, Bryan Johnson — the investor and founder behind the Don’t Die movement – wants to start “foodome” sequencing.  “We’re going to sequence the U.S. ‘foodome,’ which means test 20% of foods that constitute 80% of the American diet based on stuff

Anti-aging zealot Bryan Johnson wants to start ‘foodome sequencing’ Read More »

Elea AI is chasing the healthcare productivity opportunity by targeting pathology labs’ legacy systems

VC funding into AI tools for healthcare was projected to hit $11 billion last year — a headline figure that speaks to the widespread conviction that artificial intelligence will prove transformative in a critical sector. Many startups applying AI in healthcare are seeking to drive efficiencies by automating some of the administration that orbits and

Elea AI is chasing the healthcare productivity opportunity by targeting pathology labs’ legacy systems Read More »

Virtual physical therapists Hinge Health files for IPO, estimated to raise $500M

Hinge Health, a 10-year-old company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions, filed to go public. Although Hinge has not yet announced how many shares, nor priced them, the IPO specialists at Renaissance Capital estimate the company hopes to raise up to $500 million in its offering. Hinge’s revenue in 2024

Virtual physical therapists Hinge Health files for IPO, estimated to raise $500M Read More »

Radiology AI software provider Gleamer expands into MRI with two small acquisitions

Medical imaging is a broad term that encompasses several distinct technologies. After working on AI-powered tools to enhance X-rays and mammographies, French startup Gleamer now aims to tackle magnetic resonance imaging (MRI). Instead of starting from scratch, Gleamer has acquired two startups that have already been working on AI-powered MRI analysis: Pixyl and Caerus Medical.

Radiology AI software provider Gleamer expands into MRI with two small acquisitions Read More »